US Markets Market Outlook

  • Draghi needs to walk the talk: Expert

    Willem Nabarro, Head of European Equities for Asia at Exane-BNP Paribas, expects the ECB to roll out a bond-buying program worth a minimum of 500 billion euros and outlines the European stocks that he likes.

  • Draghi could deliver more than expected: Pro

    Jacob Kirkegaard, Senior Fellow at Peterson Institute for International Economics, says the European Central Bank could overshoot expectations to roll out an asset purchase program worth more than 500 billion euros.

  • Cramer: Hold this stock for the long term

    Forget the haters, "Mad Money" host Jim Cramer says this stock could be a lock for the long haul.

  • SGX: Derivatives will remain a 'growth sector'

    Magnus Bocker, CEO of the Singapore Exchange, explains why growth in its derivatives business will be intact for a couple of years, even as the rest of the region moves toward developing their own financial derivatives markets.

  • SGX: Too early to judge effects of new board lot size

    Magnus Bocker, CEO of the Singapore Exchange, discusses the muted response to the change in minimum lot sizes, which aims to make Singapore-listed blue-chips more accessible to retail investors.

  • Sit back & enjoy the show: Cramer's take on NFLX

    Mad Money's Jim Cramer provides insight into upgrades by both Cowen and Stifel on Netflix.

  • Amicus Therapeutics CEO: Driving science to a cure

    John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC's Jim Cramer.

  • Investors are looking to the ECB to live up to a lofty advance billing as it tries to resurrect the region's economy.

  • Cramer: This was a Netflix day

    Mad Money host Jim Cramer focuses on the cause of today's rally. Today's strength was triggered by Netflix, says Cramer.

  • Top activist plays for 2015

    13D Monitor outpaced the S&P 500 for the third straight year. Insight into its methods, with founder and principal Ken Squire.

  • High yield, bad buy?

    Why a stock with high yield may not be a good buy, with Paul Hickey, Bespoke.

  • JPM ridiculously cheap: Finerman

    JPMorgan's Jamie Dimon said earlier on CNBC its diversification makes the bank stronger. The FM crew trades the name.

  • Why you shouldn't be fighting central banks

    Jack Bouroudjian, Chief Investment Officer of Index Financial Partners, explains how central bank actions may impact financial markets and describes how investors should react.

  • Amazon Prime box, Amazon Prime

    The "Fast Money" traders discuss ways to trade stocks that are facing big changes in the new year.

  • Raymond James CEO: Drivers all up

    Raymond James CEO Paul Reilly, outlines the positive drivers of business contributing to a quarter of good growth.

  • Jon Najarian: Many energy names severely oversold

    Discussing President Obama's State of the Union address and the impact of lower oil prices, with CNBC contributor Jimmy Pethokoukis; Jon Najarian; " Fast Money" trader Brian Kelly; and CNBC's Kayla Tausche.

  • We relish big market moves: Pro

    What the current scale of volatility means for the market, with David Sherman, Cohanzick Management, and Matt Cheslock, Virtu Financial.

  • Commodities tomorrow: Oil up on the day

    CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets. Oil was up on the day, as traders continued to seek the bottom. Nat gas was up on colder weather forecasts, and gold was down today.

  • Betting on bonds

    Topping the benchmark, Michael Hyman, Invesco, is focused on U.S. centric risk opportunities.

  • Street Talk: CVS, AMAT, AMD & more

    "Street Signs" hosts Mandy Drury and Brian Sullivan look at 5 stocks with analyst recommendations, including Credit Suisse getting bullish on both Applied Materials and Lam Research.